Ambarella is an edge-AI semiconductor innovator with a narrow moat but faces structural constraints. Read why AMBA stock is a ...

Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported third-quarter 2025 results and provided the following highlights and recent developments: ...

Get key insights from Pacira BioSciences’ Q3 2025 earning call: EXPAREL growth, updated guidance, new pipeline moves & margin outlook.

Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024 ...

Baxter’s Q3 profit rose 41% year-over-year, but gross margin plunged 430 basis points to 39.4% amid higher manufacturing costs and weak IV solution demand. ・The company cut its 2025 EPS and sales ...

Scott Galovan stated, "We currently estimate the P&L impact of incremental tariff-related manufacturing costs, primarily for ...

Fourth Quarter 2025 Diluted earnings per share (“EPS”) of $0.79 and Adjusted EPS of $1.70Fiscal Year 2025 Diluted EPS of ...

Quarterly revenue of $634 million and adjusted EBITDA of $58 million ; GAAP income of $0.76 /share and adjusted EPS of $0.39 DALLAS, Nov.

Q3 2025 Earnings Call Transcript November 13, 2025Vinci Compass Investments Ltd. misses on earnings expectations.

Q3 2025 Management View Andrew Hider, President, Chief Executive Officer, addressed his first earnings call, emphasizing both the foundational strengths and the urgent need for improvement at Baxter.

THOUSAND OAKS, Calif., Nov. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2025.

For the quarter ended September 30, 2025, total operating revenues at Altira Macau were US$25.6 million, compared with US$30.5 million in the third quarter of 2024. Altira Macau's negative Adjusted ...